title: Promise of new Alzheimer's drug is dashed after lack of evidence.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D017211:Treatment Failure
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C550616:solanezumab